1
1
1
1
5
5
7
7
3
3
2
2
1
1
2014
2008
Company (20)Research Institution (2)University (1)
1 - 10 of 20
Sort by
SEC Filing
Accession Number0001140361-14-003026Form TypeDAcceptance Date2014-01-23
Sold $8,085,705 of $8,085,705 of Equity and Option to Acquire
SEC Filing
Accession Number0001140361-13-039588Form TypeDAcceptance Date2013-10-25
Sold $6,850,850 of $8,195,441 of Equity and Option to Acquire
SEC Filing
Accession Number0001140361-13-001149Form TypeDAcceptance Date2013-01-04
Sold $5,850,851 of $5,850,851 of Equity
Clinical Trial
Clinical Trial IDNCT01586533Start Date2012-06-01PhasePhase 2Study TypeInterventionalStatusUnknown status
This double-blind, randomized, comparator-controlled Phase II study is designed to establish the safety and efficacy of Zoenasa Rectal Gel compared to mesalamine enema in subjects with left-sided ulcerative colitis, as measured by the modified ulcerative colitis disease activity index (UCDAI), over 6 weeks of treatment. In this study, two cohorts of subjects will receive either Zoenasa-1:4 (1.0g NAC; 4.0g 5-ASA) investigational drug enema therapy or comparator mesalamine enema (4.0g 5-ASA). T…
Patent
Publication NumberUS 20120111756Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2009-12-16Publication Date2012-05-10
Disclosed are enema solutions or suspensions comprising 5-aminosalicylic acid, or a pharmaceutically acceptable salt or ester thereof, and N-acetylcysteine, or a pharmaceutically acceptable salt or ester thereof, methods of preparing the same, and bottles and packages containing the same.
Patent
Publication NumberUS 20120093939Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2009-12-16Publication Date2012-04-19
Disclosed are pharmaceutical compositions comprising immediate release and sustained release formulations of 5-aminosalicylic acid, or a pharmaceutically acceptable salt or ester thereof, and/or N-acetylcysteine, or a pharmaceutically acceptable salt or ester thereof, for release in the lower gastrointestinal tract.
SEC Filing
Accession Number0001140361-11-056653Form TypeDAcceptance Date2011-12-08
Sold $1,970,243 of $1,970,243 of Debt and Option to Acquire
Patent
Publication NumberEP 2367421 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2009-12-16Publication Date2011-09-28
Patent
Publication NumberEP 2367422 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2009-12-16Publication Date2011-09-28
Patent
Publication NumberAU 2009333300 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2009-12-16Publication Date2011-08-11
Disclosed are pharmaceutical compositions comprising immediate release and sustained release formulations of 5 -aminosalicylic acid, or a pharmaceutically acceptable salt or ester thereof, and/or N-acetylcysteine, or a pharmaceutically acceptable salt or ester thereof, for release in the lower gastrointestinal tract.
We found 20 documents that match your Search
Patents: 12
Clinical Trials: 2
SEC Filings: 6

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in